Laboratory validation and clinical utility of next-generation sequencing-based IGH/TCR clonality testing for the monitoring of measurable residual disease in acute lymphoblastic leukaemia: real-world experience at Austin Pathology
Pathology · 2024-12 · 56 (7) · 982-992
DOI: 10.1016/j.pathol.2024.04.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology, 2024-12. Verfasst von Stephen B Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Austin Pathology, Heidelberg, Vic, Australia; Austin Health, Heidelberg, Vic, Australia. Electronic address: ma.stephen@icloud.com. Hauptthemen laut MEDLINE: Neoplasm, Residual, High-Throughput Nucleotide Sequencing, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Austin Pathology, Heidelberg, Vic, Australia; Austin Health, Heidelberg, Vic, Australia. Electronic address: ma.stephen@icloud.com.
- Austin Pathology, Heidelberg, Vic, Australia.
- Royal Children's Hospital, Parkville, Vic, Australia.
- South Australian Health and Medical Research Institute, Adelaide, SA, Australia; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
- Alfred Health, Melbourne, Vic, Australia.
- Alfred Health, Melbourne, Vic, Australia; Australian Centre for Blood Diseases, Monash University, Melbourne, Vic, Australia.
Zitieren
APA
Ma, S. B., Lin, W., Campbell, J., Clerici, K., White, D., Yeung, D., Gorniak, M., Fleming, S., Fong, C. Y., & Agarwal, R. (2024). Laboratory validation and clinical utility of next-generation sequencing-based IGH/TCR clonality testing for the monitoring of measurable residual disease in acute lymphoblastic leukaemia: real-world experience at Austin Pathology. Pathology, 56(7), 982-992. https://doi.org/10.1016/j.pathol.2024.04.012
Vancouver
Ma SB, Lin W, Campbell J, Clerici K, White D, Yeung D, et al. Laboratory validation and clinical utility of next-generation sequencing-based IGH/TCR clonality testing for the monitoring of measurable residual disease in acute lymphoblastic leukaemia: real-world experience at Austin Pathology. Pathology. 2024;56(7):982-992. doi:10.1016/j.pathol.2024.04.012
BibTeX
@article{Ma2024,
author = {Ma, Stephen B and Lin, Wendi and Campbell, Janine and Clerici, Kerrie and White, Deborah and Yeung, David and Gorniak, Malgorzata and Fleming, Shaun and Fong, Chun Y and Agarwal, Rishu},
title = {Laboratory validation and clinical utility of next-generation sequencing-based IGH/TCR clonality testing for the monitoring of measurable residual disease in acute lymphoblastic leukaemia: real-world experience at Austin Pathology},
journal = {Pathology},
year = {2024},
volume = {56},
number = {7},
pages = {982--992},
doi = {10.1016/j.pathol.2024.04.012}
}
EUVIMED